# Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.

> **NCT05719181** · PHASE1 · UNKNOWN · sponsor: **University of Baghdad** · enrollment: 32 (estimated)

## Conditions studied

- Hypertension
- Diabetes Mellitus
- Blood Disease

## Interventions

- **BIOLOGICAL:** rhBMP-2

## Key facts

- **NCT ID:** NCT05719181
- **Lead sponsor:** University of Baghdad
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-06
- **Primary completion:** 2023-03-18
- **Final completion:** 2023-04-20
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05719181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05719181, "Effect of Recombinant Human Bone Morphogenetic Protein-2 With an Absorbable Collagen Sponge on Stability of Dental Implant: (Split Mouth Randomized Clinical Trial Study.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05719181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*